MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.endinu.2019.03.018

Медицинская библиотека · Endocrinologia, diabetes y nutricion · 2019

Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study.

Pirola Ilenia, Rotondi Mario, Cristiano Alessandra, Maffezzoni Filippo, Pasquali Daniela, Marini Fiorella, Coperchini Francesca, Paganelli Matteo, Apostoli Pietro, Chiovato Luca, Ferlin Alberto, Cappelli Carlo

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

The purpose of this prospective study was to assess the effects of selenium supplementation on TSH and interferon-γ inducible chemokines (CXCL9, CXCL10 and CXCL11) levels in patients with subclinical hypothyroidism due to Hashimoto's thyroiditis.

PATIENTS AND

METHODS

Patients with subclinical hypothyroidism due to Hashimoto thyroiditis were prospectively enrolled in the SETI study. They received 83mcg of selenomethionine/day orally in a soft gel capsule for 4 months with water after a meal. No further treatment was given. All patients were measured thyroid hormone, TPOAb, CXCL9, CXCL10, CXCL11, iodine, and selenium levels at baseline and at study end.

RESULTS

50 patients (43/7 female/male, median age 43.9±11.8 years) were enrolled, of which five withdrew from the study. At the end of the study, euthyroidism was restored in 22/45 (48.9%) participants (responders), while 23 patients remained hypothyroid (non-responders). There were no significant changes in TPOAb, CXCL9, CXCL10, CXCL11, and iodine levels from baseline to the end of the study in both responders and non-responders. TSH levels were re-tested six months after selenomethionine withdrawal: 83.3% of responding patients remained euthyroid, while only 14.2% of non-responders became euthyroid.

CONCLUSIONS

The SETI study shows that short-course supplementation with selenomethionine is associated to a normalization of serum TSH levels which is maintained 6 months after selenium withdrawal in 50% of patients with subclinical hypothyroidism due to chronic autoimmune thyroiditis. This TSH-lowering effect of selenium supplementation is unlikely to be related to changes in humoral markers of autoimmunity and/or circulating CXCL9.

Для цитирования: Pirola Ilenia, Rotondi Mario, Cristiano Alessandra, Maffezzoni Filippo, Pasquali Daniela, Marini Fiorella, Coperchini Francesca, Paganelli Matteo, Apostoli Pietro, Chiovato Luca, Ferlin Alberto, Cappelli Carlo. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study.. Endocrinologia, diabetes y nutricion. 2019. DOI: 10.1016/j.endinu.2019.03.018.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.